Project Grant R21EB034413
Award Date
8/1/23
Completion Date
7/31/25
Dollars Obligated
$451K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The National Cancer Institute (CFDA 93.396 - Cancer Biology Research) awarded Loyola University of Chicago a $461,844 project grant titled "Hyperpolarized 13C Metabolic Imaging of Tumorigenesis in the Liver". The objective is to use novel hyperpolarized 13C probes to image glycolysis, a critical pathway in hepatocellular carcinoma (HCC) development, and establish in vivo imaging biomarkers to assess altered liver metabolism during HCC progression. The project aims to synthesize a...
This Project Grant award, valued at $407,113 and funded by the National Cancer Institute under the Cancer Biology Research (CFDA 93.396) program, supports the development of a novel bio-orthogonal mid-infrared photothermal (MIP) imaging approach to study cancer cell metabolism. The grant recipient, Trustees of Boston University, will undertake a three-part research effort: Building a library of nitrile-based probes to sense key molecular events within cancer cells. Developing nitrile-tagged...
This $574,322 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) will fund research to address the challenge of analytic variability associated with the choice of modeling approach for in-vivo proton magnetic resonance spectroscopy (1H-MRS) data. The project aims to develop novel data analysis strategies that involve...
This federal Project Grant award of $174,375.00 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research to develop new methods for incorporating fluorine-18 into complex molecules using irreversible metal-fluorine bond formation. The broad aims of the project are to expand the radiofluorination toolbox for molecular imaging, particularly...
This $505,848.59 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop new methods for rapidly producing fluorine-18 labeled organic compounds for use as positron emission tomography (PET) imaging agents. The key objectives are to: 1) Optimize an amide C-H radiofluorination protocol to create a wide range of...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will support research to optimize polymeric chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) agents for prostate cancer detection. The $185,171 award will fund the synthesis and characterization of CEST MRI agents with varying charge and hydrophilicity...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $678,515 to The University of Texas MD Anderson Cancer Center to evaluate an innovative molecular imaging approach to predict response to yttrium-90 (Y90) radioembolization therapy for hepatocellular carcinoma (liver cancer). The key objectives are to: 1) Evaluate the relationship between the imaging biomarker 18F-FSPG PET, circulating tumor DNA...
This federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $497,870 to the University of Cincinnati to develop novel nuclear imaging probes based on bacterial metallophores. The goal is to genetically engineer mammalian cells, such as CAR-T cells, to express bacterial transporter proteins that can selectively bind and retain copper-64 (64Cu) metallophore complexes. This would enable non-invasive in vivo tracking and...
The National Cancer Institute (NCI) awarded a $400,000 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to O2M Technologies LLC, a small for-profit company specializing in advanced oxygen imaging technology using electron paramagnetic resonance (EPR) techniques. The goal of this 1-year project, with a period of performance from September 2024 to August 2025, is to develop a multifunctional imager (MFI) capable of simultaneously acquiring tissue oxygen...
This $421,744 Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports research to develop a peptide multimer for early detection of hepatocellular carcinoma (HCC), a rapidly growing cancer. The project aims to identify promising imaging biomarkers for HCC by examining molecular pathogenesis using single-cell RNA sequencing and evaluating peptide-based multimers that can target multiple HCC-specific cell surface markers. The multimer...